Summary: Genomic screening of hybrids from stroke-prone (SHR-SP) and stroke-resistant spontaneously hypertensive rats (SHR) identified a STRllocus on the rat chromosome 1, which correlates with the susceptibility to cerebral stroke but not with hypertension. The authors examined whether this genetic ab normality is associated with hemodynamic or metabolic alter ations in the brain that can be detected before the manifestation of brain infarction. Starting at 6 weeks of age, SHR-SP were fed with a salt-rich diet to accelerate arterial hypertension. At the age of 12 weeks, animals developed functional symptoms and were age-matched with symptom-negative SHR-SP to dif ferentiate between presymptomatic and postsymptomatic changes. Brains were investigated by multiparametric imaging comprising quantitative double-tracer autoradiography of CBP and cerebral protein synthesis (CPS); bioluminescence imaging of regional ATP, glucose, and lactate content; and umbellifer one fluoroscopic imaging of tissue pH. None of the animals exhibited focal hemodynamic or biochemical abnormalities. In symptom-negative SHR-SP, global CBP was 1.1 ± 0.3 mL .
Clinical and epidemiologic studies reveal that genetic factors play an important role in the pathogenesis of CNS diseases (Alberts, 1991; Brass and Alberts, 1995; Brass et ai., 1992; Kiely et ai., 1993) . With the advent of new methods for molecular genetic research and statistical evaluation (Hauser et ai., 1996; Lander and Botstein, 1986a,b; Payne and Roses, 1988; Pinto et ai., 1998; Risch, 1990; Schork et ai., 1993) and with the establish ment of a spontaneously hypertensive rat (SHR) strain with a high incidence of stroke (SHR-SP) (Yamori et ai., 1975a,b) , it has become possible to analyze the genetic background of cerebrovascular disease under controlled experimental conditions (Coyle et ai., 1984; Jeffs et aI., 1997; Rubattu et aI., 1996) . Rubattu et ai. (1996) report that hybrids from SHR-SP and stroke-resistant SHR exhibit a quantitative trait locus STRI on rat chromosome 1, which correlates with the susceptibility of stroke but not with hypertension. The pathomechanisms of this relation remain to be estab lished, but there are indications of a progressive cerebro vascular angiopathy in SHR-SP (Arribas et aI., 1996; Baumbach, 1996; Fredriksson et aI., 1988; Ogata et aI., 1980; Ogata et aI., 1981) . These vascular changes have been associated with focal reductions of blood flow (Ogata et aI., 1980; Ogata et aI., 1981; Yamori and Horie, 1977) , which lead to focal disturbances of energy me tabolism and eventually infarction (Paschen et aI., 1985a; Yamori and Horie, 1977) . Other studies, how ever, indicate that a prominent feature of SHR-SP is a disturbance of vascular reactivity, as confirmed by the shift of the lower limit of CBF autoregulation (Barry et al., 1982; Sadoshima and Heistad, 1983) or reduced Peo2-reactivity of brain perfusion (Yamori and Horie, 1977) . We therefore examined the relation between blood flow and metabolism before the onset of brain infarcts in SHR-SP. For regional analysis, we used a multiparametric imaging protocol, which allows the si multaneous measurement of CBF and cerebral protein synthesis (CPS) (Mies et al., 1993) ; tissue ATP, glucose, and lactate values (Kogure and Alonso, 1987; Paschen, 1985; Paschen et al., 1985b) ; as well as the visualization of regional differences in tissue pH in the same animal (Csiba et al., 1983 ). Our observations demonstrate that SHR-SP exhibit global rather than focal flow abnormali ties before infarction and that the initial metabolic change is a global inhibition of protein synthesis rather than a focally disturbed energy state.
MATERIALS AND METHODS

Animals and functional deficit score
Male SHR-SP siblings weighing 80 to 100 g were obtained from the Max-Delbriick-Center for Molecular Medicine in Ber lin-Buch and housed with a 12-hour light-dark cycle under constant temperature conditions. At the age of 6 weeks, the rats received a salt-rich diet (17.5% protein, 3.7 mg/g Na+, 6.3 mg/g K+, 0.03 mg/ fl methionine; Lab. Piccioni, Milan, Italy) a ? d 1 % NaCI in the drinking water ad libitum. The progressIOn of disease was monitored by daily evaluations of changes in body weight and of signs of behavioral and neurologic deficits ac cording to the criteria listed in Table 1 . Ten SHR-SP exhibiting a functional deficit score of more than 5 points were designated as symptom positive (S+) and matched with 10 symptom negative (S-) rats of the same age and the same duration of salt diet. The cutoff of 5 points was chosen to differentiate between animals with and without motor deficits. The pairs of ani mals--except one symptom-positive animal that died sponta neously-then were subjected to multiparametric imaging as described later.
Experimental protocol
General surgery. Animals were anesthetized with 1.5% halo thane in 70% N20 and 30% oxygen delivered with a face mask. Rectal temperature was kept between 36.5° and 37.5°C throughout the experiment using a feedback-controlled heating system. Catheters were inserted into both femoral arteries and veins for injection of drugs and tracers, arterial blood sampling, and arterial blood pressure monitoring. Animals were trache- Animals with a functional deficit score :s5 points were classified as symptom negative (S-), and >5 points as symptom-positive (S+). SHR SP, stroke-prone spontaneously hypotensive rats.
otomized, immobilized with pancuronium bromide (0.5 mg/ kg/h intravenously), and mechanically ventilated. After sur gery, the halothane concentration was reduced to 0.8%. Arterial blood gas analysis was performed before tracer injection.
Tracer application. One millicurie of eHl-4,5-leucine dis solved in 1 mL of Ringer solution (specific activity 140 to 170 Cilmmol) was applied by programmed intravenous infusion to maintain a constant level of plasma specific activity throughout the 45-minute circulation period (Patlak and Pettigrew, 1976) . Arterial blood samples were collected at intervals of 10 minutes and centrifuged immediately. Ten microliters of plasma were deproteinized with 10 ILL of 10% trichloroacetic acid, centri fuged, and stored in a freezer at -80°C for the later determi nation of plasma free leucine specific activity, as described later. Forty-five minutes after the beginning of eH]leucine in fusion, 30 ILCi of e4C]iodoantipyrine (specific activity 55 mCii mmol, dissolved in I mL of 0.9% saline) was infused intrave nously over 60 seconds while taking repeated blood samples on preweighed filter paper. At the end of the e4C]iodoantipyrine infusion, the animals' heads were frozen in liquid nitrogen.
Measurement of arterial t4c Jiodoantipyrine blood radioac tivity. Blood samples were weighed immediately after termina tion of experiments and placed in counting vials. A 5-mL scin tillation cocktail was added, and the [14C]radioactivity was measured in a scintillation counter (Wallace 1410, Pharmacia, Freiburg, Germany).
Tissue processing for multiparametric imaging
Double-tracer autoradiography. Brains were removed from the skull in a low-temperature cabinet at -20°C and cut into 20 ILm thick serial sections at the same temperature. Quantitative double-tracer autoradiography of e4C] and eH] was performed according to Mies et al. (1991) with minor modifications (Mies et aI., 1993 Bioluminescence imaging of regional ATP, glucose, and lac tate. For bioluminescence imaging, alternate 20 ILm thick cryo stat sections were mounted on coverslips at -20°e. After freeze drying and heat fixation, sections were coated with a layer (60 ILm) of frozen reaction mix for substrate-specific biolumines cence of ATP (Kogure and Alonso, 1978) , glucose (Paschen et aI., 1985b) , and lactate (Paschen, 1985) . Sections were allowed to thaw at room temperature, and the substrate-dependent light reaction was recorded on photographic film. For calibration of bioluminescence images, cortical samples were collected from the tissue block, and ATP, glucose, and lactate concentration were determined by conventional enzymatic tissue analyses (Lowry and Passonneau, 1972) .
Fluoroscopic imaging of tissue pH. Regional tissue pH was measured with the umbelliferone technique described by Csiba et al. (1983) . Cryostat sections, 20 ILm thick, were mounted on umbelliferone-soaked paper at -20°e. After thawing the sec tions in an ice bath, the pH-dependent fluorescence was pho tographed at 370 nm and the pH-independent fluorescence at 340 nm using a cutoff filter of 450 nm. Images were calibrated with graded pH standards.
Histology.
After eH]autoradiography of perchloric acid fix ated cryostat sections, these sections were stained with cresyl violet for light microscopic examination of morphologic le sions in gray and white matter.
Measurement of leucine-specific activities
Preparation of tissue and plasma samples. Specific activity of free tissue leucine was measured in samples taken from the frontal pole. Tissue probes were homogenized in 10 volumes of 10% trichloracetic acid, equilibrated for 30 minutes at 4°C, and then centrifuged. Pellets were washed with five volumes of 5% trichloracetic acid and centrifuged again. Supernatants were pooled and used for leucine analysis as described later.
HPLC analysis and scintillation counting. Amino acid analysis was performcd by HPLC using an automated HPLC system (Kontron D450, Munich, Germany). eHjradioactivity of the collected leucine fraction was measured in a liquid scin tillation counter (L7200 Beckman, Fullerton, CA, U.S.A.) with internal quench correction (Mies et a!., 1997) .
Data processing for multiparametric imaging
Quantitative autoradiography, bioluminescence, and fluoro scopic imaging. Autoradiograms and bioluminescence and fluorescence images were digitized with their respective stan dards using a charge-coupled device camera (Sony SSC M370CE, Sony Incorporation of America, Cypress, CA, U.S.A.) or II. microdensitometer (Scandig3, New Hampshire, England) operated by a Macintosh IIfx computer. Image pro cessing was carried out with ImageMG, a user-revised version of the public domain program NIH-Image (W. Rasband, Na tional Institutes of Health, Bethesda, MD, U.S.A.). For quan tification of images, optical densities were correlated with stan dard values by polynomial regression.
Quantitative measurement of cerebral protein synthesis. For the quantification of eHlleucine incorporation autoradiograms, the operational equation of Smith et a!. (1988) was used with the following modifications (Mies et a!., 1997) . In the denomi nator, integrated arterial plasma leucine-specific activity was multiplied by the individual precursor pool dilution factor de termined for each animal (i.e., the ratio of tissue leucine to plasma leucine specific activities). This procedure corrects for individual recycling of unlabeled amino acids derived from the breakdown of brain proteins. Global CPS values were calcu lated by averaging the pixel values of all brain slices, and region of interest values by averaging pixels of various ana tomical structures, as defined in a rat brain atlas (Pellegrino et a!., 1979) .
Quantitative measurement of cerebral blood flow. Cerebral blood flow values were derived from [14C]iodoantipyrine au toradiograms using the algorithm of Sakurada et a!. (1978) . Global and region of interest values of CBF were calculated in the same way as for CPS.
Statistical analysis
All values are expressed as means ± SD. Group differences were analyzed by one-way analysis of variance and the post hoc Scheffe test. Regression and correlation analyses were used to estimate the interdependency of parameters of interest using StatView (Abacus Concepts, Inc., Berkely, CA, U.S.A. 
RESULTS
Evaluation of the deficit score
During the initial 5 weeks of exposure to a stroke permissive salt diet, SHR-SP did not exhibit behavioral abnormalities or losses of body weight. From 38 to 40 days after the beginning of salt diet, a gradually increas ing number of rats developed functional deficits, such as exploration deficits and gait deficits. According to the definition given in the methods section, animals with a neurologic deficit score of more than 5 points were clas sified as S+ SHR-SP. When these animals were submit ted to the experimental protocol 3 to 6 hours later (mean latency after the onset of diet 42,2 ± 3.0 days), the neu rologic deficit score was 21. 1 ± 6.5 points compared with 1. 18 ± 1.8 points in the age-matched S-SHR-SP (P <0.01). Weight loss over the 3 days preceding the onset of neurologic symptoms amounted to 21.1 ± 6.5 g in S+ and 7,5 ± 7.2 g in S-rats. This difference also was highly significant (P <0.00 1).
Physiologic variables
Mean arterial blood pressure, pH, Pao2, and Paco2 did not differ significantly between S+ and S-rats (Table 2 ). The only abnormality in S+ animals was a decrease of blood hematocrit, which declined by almost 5% com pared with S-rats (P <0,0 1).
Histologic evaluation
Although the use of cresyl-violet stained cryostat sec tions does not allow the evaluation of minor neuropatho logic changes, light microscopic examination of section from both S-and S+ SHR-SP clearly revealed no evi dence for overt brain infarction. In three of nine S+ SHR SP, subcortical white matter appeared discretely wider than in other animals but showed no signs of structural damage. This suggests that the functional deficits of S+ SHR-SP were not associated with morphologic lesions. Fig. 1 ).
Notice global decline of CBF and CPS but no regional abnormalities except periventricular alkalosis.
spectively. Blood flow, protein synthesis, tissue pH, and the regional content of ATP, glucose, and lactate were measured in five coronal planes spread 2 mm apart. In the S-rat (Fig. 1) , no focal abnormalities were observed, except a slight elevation of pH in peri ventricular and white matter. In the S+ animal (Fig. 2) , in contrast, a marked reduction of blood flow and protein synthesis occurred, mainly in the cerebral cortex (Fig. 2) . Com pared with S-SHR-SP, ATP, glucose, and lactate con tent in S+ SHR-SP did not differ significantly, but there was a further increase of peri ventricular and white matter alkalization (Fig. 2) . Enzymatic measurements of metabolites in tissue samples taken from cerebral cortex demonstrated that lactate was mildly elevated, but ATP and glucose were in the normal range in both groups. In S+ SHR-SP, ATP, glucose, and lactate concentration amounted to 2.9 ± 0.8 (range 1.9 to 4.1), 2.5 ± 1.0 (range 1.3 to 4.8), and 3.1 ± 0.7 (range 2.1 to 4A) j..L mol/g, and in S-SHR-SP to 3.1 ± 0.3 (range 2.9 to 3.9), 3.1 ± 1.3 (range 1.2 to 5.5), and 3A ± OA (range 2.0 to 4.1) j..L mol/g, respectively (no significant differences between groups). No change in cortical tissue pH was observed between S-SHR-SP (7.1 ± 0.1 units; range 7.03 to 7.24) and S+ SHR-SP (7.1 ± 0.1 units; range 6.9 to 7.21).
The quantitative evaluations of CBF and CPS are sum marized in Tables 3 and 4 . Global CBF was 1. 1 ± 0.3 (range 0.7 to 1.6) mL . g-l . min-1 in S-SHR-SP but declined by 33% to 0.7 ± 0.2 (range 0.6 to 1.1) mL . g-l min-1 in S+ SHR-SP. Global CPS declined by 16% from 8.6 ± 1.2 (range 6.2 to 10.6) to 7.2 ± 2.1 (range 3.8 to lOA) nmol . g-I . min-1 after appearance of functional symptoms, but this difference did not reach statistical significance (P < 0.088). Analysis of regional CBF and CPS, however, confirmed a widespread reduction in S+ SHR-SP in most of the evaluated brain structures, with the only exception of hippocampal CPS and CPS in tha lamic ventral nucleus, which did not differ significantly between the two groups.
Correlation analyses
The decline in global brain perfusion correlated sig nificantly with both the functional deficit score ( Fig. 3 ; y = 38.1 -55.7x + 20.7x 2 ; r = 0.717; P < 0.001) and global protein synthesis ( Fig. 4 ; y = -1.7x + 14.3 -4.0/x; r = 0.634; P < 0.05). Within cerebral cortex ( Fig.  5 ; y = O.lx + 12.7 -4.l/x; r = 0.704; P < 0.001) and caudate-putamen (not shown; y = -2.8x + 11.7 -3.7/x; r = 0.524; P < 0.01), pixel analyses revealed a similar relation between local CBF and local protein synthesis. Interestingly, no such relation was seen in the hippocam pal (y = 5.5x + 3.3 + 2.5/x; r = 0.254; not significant) and thalamic (6 = -0.3x + 8.5 -2.l/x; r = 0.186; not significant) formation or in the white matter (y = -4.7x -45.8 -0.008/x; r = 0.137; not significant).
DISCUSSION
In SHR-SP, focal neurologic symptoms such as hemi paresis or abnormal circling behavior have been associ- ated with the manifestation of morphologically (Ogata et aI., 1981) or biochemically identifiable brain infarcts (Paschen et aI., 1985a) . To capture the earliest of phase of infarction which occurs in this strain before the forty third day after beginning of the salt diet (Rubattu et aI., 1996) , we selected animals for our investigation in which subtle functional symptoms were detected that had not progressed to the full neurologic symptomatology of stroke. In addition, age-matched symptom-free animals were studied to identify the presymptomatic brain dis ease. Our data demonstrate that brains of animals without .s 8 Notice the exponential decline of CPS with decreasing flow val ues (n = 10 symptom-negative and n = 9 symptom-positive SHR SP; r = 0.634; P < 0.05). (n = 10 symptom-negative and n = 9 symptom-positive SHR-SP; r = 0.704; P < 0.00 1).
HEMODYNAMICS AND METABOLISM IN SHR-SP RATS BEFORE BRAIN INFARCTION
clinical deficits did not exhibit any major brain disease and that, in the early symptomatic animals, hemody namic alterations were global rather than focal, as would be expected just before the manifestation of massive brain infarcts. Analysis of the multiparametric imaging data reveals that before the onset of brain infarction, blood flow and protein synthesis-but not A TP-are re duced throughout the brain in SHR-SP. Obviously, glob al blood flow declines at the onset of functional symp toms to levels that interfere with protein synthesis but not with energy metabolism (Mies et aI., 1991) . Because a decrease in brain perfusion is associated with a decline in tissue oxygen tension (Crockard et aI., 1976; Back et aI., 1994) , the most likely explanation for the disturbance of the protein synthesizing machinery is the known sensi tivity of brain protein synthesis of hypoxia (Metter and Yanagihara, 1979) . Notice that pixel analysis with the rational function (i.e., y = a*x + b + c/x) revealed a significant flow threshold-dependent decline of cortical and striatal CPS, whereas such interdependency did not reach the level of significance in the hippocampal for mation, thalamic nuclei, or white matter. This suggests that in the latter structures, the CBF-CPS interdepen dency probably is more complex. A significant flow de pendency of CPS inhibition in cortex and caudate putamen could be related to the oxygen sensitivity of CPS, but it cannot be excluded, as for the other examined structures, that regional flow is partially coupled to the reduction of the metabolic rate for glucose. In such an instance, the decrease in regional blood flow might have been unrelated to changes in the rates of protein synthe sis. Further studies are necessary to clarify this issue. The manifestation of brain infarcts follows later, when blood flow falls to the lower threshold of A TP break down (Mies et aI., 1991) . This event occurs first in the 1244 G. MIES ET AL.
areas in which flow impairment is most pronounced, which explains the focal localization of infarctions (Ogata et a!., 1980; Ogata et a!., 1981) . If this interpre tation is correct, the clinical symptoms observed here of exploration deficits and torso rotation reflect brain dis turbances that occur at higher flow rates than those caus ing brain infarction, and such symptoms would be seri ous predictors of impending stroke.
Our observations of an initially global reduction of blood flow in SHR-SP are in line with the earlier dem onstration of progressive vascular disease in this strain. Nordborg and Johansson (1980) showed that the ratio of the vessel wall thickness to the diameter of medium sized intraparenchymal arteries and larger vessels (e.g., internal carotid artery) was significantly increased in SHR already at an age of 15 days compared with Wi star Kyoto rats, probably because of differences in the ge netic background of these rat strains. During the progres sive development of arterial hypertension in SHR, a con tinuous remodeling and reconstruction of extracranial and perforating arteries, as well as intraparenchymal ce rebral arterioles, occurred, which led to a further increase in the wall-lumen ratio and wall thickness caused by hypertrophy of vascular smooth muscle cells (Arribas et a!., 1996; Baumbach, 1996; Nordborg and Johannson, 1980) . These structural alterations might explain the in creased cerebrovascular resistance in SHR and SHR-SP needed for the normalization of blood pressure before it reaches the microcirculation (Folkow, 1982) . Light mi croscopic and ultrastructural studies further reveal that the initial vascular lesions included focal cytoplasmic necrosis in the outer layer of the media progressing to widespread medial necrosis without damage to the en dothelium (Tagami et a!., 1987) .
After the manifestation of brain infarction, histologic examination showed typical vascular damage, such as hyaline degeneration of small intracerebral arterioles of less than 30 /-Lm in diameter and subintimal deposition of fibrinoid material in neocortical infarct, and, to a lesser extent, in the basal ganglia (Ogata et a!., 1981) . Such fibrinoid vascular lesions, in which damaged endothelial and smooth muscle cells were replaced by fibrin-like material, were located mainly in arterial border zones, showing stenosis and occasionally thrombotic occlusion of the lumen (Fredriksson et a!., 1985; Fredriksson et a!., 1988) . In addition, increased vascular permeability (Shibota et a!., 1978; Tamaki et a!., 1984) and edema (Fredriksson et a!., 1987; Kalimo et a!., 1986; Paschen et a!., 1985a) were observed within and around such le sions. Consequently, the regulatory failure of the vascu lature leading to critically reduced flow levels in circum scribed brain regions was thought to be responsible for the onset of stroke in these animals (Paschen et a!., 1985a; Tamaki et a!., 1984; Yamori and Horie, 1977) .
In two studies, the vascular alterations developing dur- ing the asymptomatic stage of SHR and SHR-SP were shown to cause a gradual decline in CBF (Katayama et a!., 1997; Yamori and Horie, 1977) , which we and others (Fredriksson et a!., 1984; Hoffman et a!., 1982; lzuta et a!., 1995; Nishiyama et a!., 1976) could not confirm. It remains to be clarified whether in both of these studies this resulted from an age-dependent decrease in cerebral perfusion or was brought about by the vascular angiopa thy. In other flow studies on age-matched normotensive Wistar Kyoto rats and S-SHR and SHR-SP, no differ ences in global in regional brain perfusion were observed between the various strains (Fredriksson et a!., 1984; Hoffman et a!., 1982; lzuta et a!., 1995; Nishiyama et a!., 1976) . The regulatory capacity of brain perfusion, how ever, was found to be disturbed in chronic hypertension. Symptom-negative SHR showed a shift of the lower limit of CBF autoregulation, which increased the suscep tibility to ischemic brain damage during hypotension (Barry et a!., 1982; Sadoshima and Heistad, 1983 ). An other indicator of a disturbed vasodilatory response of the arterial vessels is a reduced Pco2-reactivity of brain perfusion in SHR-SP before stroke onset (Yamori and Horie, 1977) . Compared with normotensive rats, the di lator reserve of cerebral collateral vessels was reduced in SHR-SP, suggesting structural differences in those ves sels (Coyle, 1987) . Experimental results indicate that the blood flow through cerebral collaterals is much lower in SHR-SP (Coyle and Heistad, 1986) and thereby pro duced larger brain infarcts after occlusion of the middle cerebral artery in SHR-SP (Coyle and Jokelainen, 1983; Coyle et a!., 1984) .
The results of the current study demonstrate that with the appearance of early functional deficits, regulation of brain perfusion was globally impaired, resulting in a global reduction of CBF but not in local flow deficits. With the reservation that the use of cryostat sections for light microscopic examinations might obscure minor his topathologic changes, morphologic lesions could be ex cluded. The decompensation of global blood flow may be related to the structural alterations of the vascular system, but changes in cerebrovascular reactivity to ar terial Pco2 cannot be excluded (Yamori and Horie, 1977) . It also has to be considered that the decline of global CBF in S+ SHR-SP could be coupled with re duced rates in glucose consumption resulting from the impairment of motor activity. Finally, abnormalities in the renin-angiotensin system should be considered. Be cause both the systemic and cerebral renin-angiotensin system play an important role in hypertension-induced vascular and cerebral lesions (Pinto et a!., 1998) and because treatment with angiotensin I converting enzyme blockers is effective in preventing or delaying the onset of cerebral stroke (Harper, 1987; Hoffman et a!., 1982; Yamori et a!., 1975b) , such therapy may provide further insights into the mechanisms of flow impairment. Ex-perimental evidence shows that treatment of SHR-SP with angiotensin I converting enzyme inhibitors resets both the lower and upper limits of autoregulation by acting on the cerebrovascular endothelium (Barry et aI., 1984; Vorstrup et aI., 1984) . Further studies are therefore warranted to clarify whether angiotensin I converting enzyme inhibition is effective in normalizing brain per fusion after the occurrence of early functional deficits, and whether this treatment could be used to prevent the subsequent manifestation of brain infarcts.
In conclusion, the results of the current study demon strate that in SHR-SP, functional symptoms appear be fore the manifestation of brain infarcts and that these symptoms are initiated by a global decline in CBF and cortical and striatal CPS. This supports the hypothesis that the genetic abnormality in this strain (i.e., the quan titative trait locus STRI on rat chromosome I [Rubattu et aI., 1996] ) is associated with a global vascular process and that acute focal decompensation of blood flow and metabolism occurs at a later stage of the disease process.
